BLOG POST

Well Done

YOUR SOURCE ON FOOD LITIGATION AND REGULATION

FSIS, FDA Announce More Flexibility in Regulatory Requirements During Pandemic

07. Mai 2020

As the public health emergency caused by the coronavirus (COVID-19) continuously evolves, the US Department of Agriculture Food Safety Inspection Service (FSIS) and the Food and Drug Administration (FDA) are actively releasing new, and updating existing, policy statements and temporary guidance providing flexibility on certain regulatory requirements during the pendency of the COVID-19 pandemic. FDA recently issued a final guidance providing the Accredited Third-Party Certification Program some flexibility. FSIS recently extended its policies for the labeling of products intended for food products going to retail through the end of July.

This chart has been revised to reflect these changes. We hope this will continue to serve as a convenient resource. We will provide additional amendments as future circumstances warrant.

Law clerk Angela Silva contributed to this post.

CORONAVIRUS COVID-19 TASK FORCE

For our clients, we have formed a multidisciplinary Coronavirus COVID-19 Task Force to help guide you through the broad scope of legal issues brought on by this public health challenge. We also have launched a resource page to help keep you on top of developments as they unfold. If you would like to receive a daily digest of all new updates to the page, please subscribe now to receive our COVID-19 alerts.